Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Som S. Mukherjee"'
Publikováno v:
Australasian Plant Pathology. 41:79-84
Water samples from Turitea Creek and the Manawatu River near Palmerston North, New Zealand were assayed for infectious plant viruses. Twenty liter water samples each were prefiltered and virions adsorbed onto electropositive Zeta Plus 50S membranes.
Autor:
Smith-Turchyn J; School of Rehabilitation Science, McMaster University, Hamilton, Canada., Mukherjee S; Department of Oncology, McMaster University, Hamilton, Canada.; Juravinski Cancer Centre, Hamilton, Canada., Richardson J; School of Rehabilitation Science, McMaster University, Hamilton, Canada., Ball E; Medical Sciences, McMaster University, Hamilton, Canada., Bordeleau L; Department of Oncology, McMaster University, Hamilton, Canada.; Juravinski Cancer Centre, Hamilton, Canada.; Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada., Neil-Sztramko S; School of Nursing, McMaster University, Hamilton, Canada., Levine O; Department of Oncology, McMaster University, Hamilton, Canada.; Juravinski Cancer Centre, Hamilton, Canada., Thabane L; Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada., Sathiyapalan A; Department of Oncology, McMaster University, Hamilton, Canada.; Juravinski Cancer Centre, Hamilton, Canada., Sabiston C; Kinesiology and Physical Education, University of Toronto, Toronto, Canada.
Publikováno v:
BMJ open sport & exercise medicine [BMJ Open Sport Exerc Med] 2020 Oct 07; Vol. 6 (1), pp. e000922. Date of Electronic Publication: 2020 Oct 07 (Print Publication: 2020).
Autor:
Kapoor A; Division of Urology, Department of Surgery, McMaster University, Hamilton, ON L8N 4A6, USA., Wong NC; Division of Urology, Department of Surgery, McMaster University, Hamilton, ON L8N 4A6, USA., Wang Y; Division of Urology, Department of Surgery, McMaster University, Hamilton, ON L8N 4A6, USA., Mukherjee S; Department of Oncology, McMaster University, Hamilton, ON L8N 4A6, USA., Hotte S; Department of Oncology, McMaster University, Hamilton, ON L8N 4A6, USA., Dayes I; Department of Oncology, McMaster University, Hamilton, ON L8N 4A6, USA., Lukka H; Department of Oncology, McMaster University, Hamilton, ON L8N 4A6, USA.
Publikováno v:
Asian journal of andrology [Asian J Androl] 2020 Jul-Aug; Vol. 22 (4), pp. 437-438.
Autor:
Leong DP, Fradet V, Shayegan B, Duceppe E, Siemens R, Niazi T, Klotz L, Brown I, Chin J, Lavallee L, Mousavi N, Luke P, Lukka H, Gopaul D, Violette P, Hamilton RJ, Davis MK, Karampatos S, Mian R, Delouya G, Fradet Y, Mukherjee S, Conen D, Chen-Tournoux A, Johnson C, Bessissow A, Dresser G, Hameed AK, Abdel-Qadir H, Sener A, Pal R, Devereaux PJ, Pinthus J
Publikováno v:
The Journal of urology [J Urol] 2020 Jun; Vol. 203 (6), pp. 1109-1116. Date of Electronic Publication: 2020 Jan 03.
Autor:
Donovan E; Department of Oncology, Division of Radiation Oncology, McMaster University, Hamilton, Ontario, Canada., Dhesy-Thind S; Department of Oncology, Division of Medical Oncology, McMaster University, Hamilton, Ontario, Canada., Mukherjee S; Department of Oncology, Division of Medical Oncology, McMaster University, Hamilton, Ontario, Canada., Kucharczyk M; Department of Medicine, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada., Swaminath A; Department of Oncology, Division of Radiation Oncology, McMaster University, Hamilton, Ontario, Canada.
Publikováno v:
The breast journal [Breast J] 2019 Nov; Vol. 25 (6), pp. 1222-1224. Date of Electronic Publication: 2019 Jul 01.
Autor:
Mackett K; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada., Dhesy-Thind S; Department of Oncology, McMaster University, Hamilton, ON, Canada., Donovan EK; Department of Oncology, McMaster University, Hamilton, ON, Canada., Mukherjee S; Department of Oncology, McMaster University, Hamilton, ON, Canada., Swaminath A; Department of Oncology, McMaster University, Hamilton, ON, Canada., Leong DP; Division of Cardiology and the Population Health Research Institute, McMaster University, Hamilton, ON, Canada., Voruganti S; Department of Oncology, McMaster University, Hamilton, ON, Canada., Sussman J; Department of Oncology, McMaster University, Hamilton, ON, Canada., Wright J; Department of Oncology, McMaster University, Hamilton, ON, Canada., Okawara G; Department of Oncology, McMaster University, Hamilton, ON, Canada., Fraser G; Department of Oncology, McMaster University, Hamilton, ON, Canada., Sagar S; Department of Oncology, McMaster University, Hamilton, ON, Canada., Bordeleau L; Department of Oncology, McMaster University, Hamilton, ON, Canada., Ellis PM; Department of Oncology, McMaster University, Hamilton, ON, Canada., Hirte H; Department of Oncology, McMaster University, Hamilton, ON, Canada., Kavsak PA; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: kavsakp@mcmaster.ca.
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2019 Aug; Vol. 495, pp. 355-357. Date of Electronic Publication: 2019 May 02.
Autor:
Goodwin PJ; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. pgoodwin@mtsinai.on.ca., Segal RJ; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Vallis M; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Ligibel JA; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Pond GR; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Robidoux A; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Blackburn GL; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Findlay B; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Gralow JR; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Mukherjee S; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Levine M; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Pritchard KI; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Jul 20; Vol. 32 (21), pp. 2231-9. Date of Electronic Publication: 2014 Jun 16.
Autor:
Tam TY; Department of Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada. tifftam@gmail.com, Mukherjee S, Farrell T, Morgan D, Sur R
Publikováno v:
Brachytherapy [Brachytherapy] 2009 Jul-Sep; Vol. 8 (3), pp. 313-7. Date of Electronic Publication: 2009 Feb 10.
Autor:
Figueredo A; Hamilton Regional Cancer Centre, McMaster Univ., Dept. of Clin. Epid. and Stat.,, 699 Concession Street, Hamilton, Ontario, Canada, L8V 5C2. alvaro.figueredo@hrcc.on.ca, Coombes ME, Mukherjee S
Publikováno v:
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2008 Jul 16 (3). Cochrane AN: CD005390. Date of Electronic Publication: 2008 Jul 16.
Autor:
Colgan SM; Department of Medicine, Juravinski Cancer Center, Hamilton, Ontario., Mukherjee S, Major P
Publikováno v:
Clinical colorectal cancer [Clin Colorectal Cancer] 2007 Mar; Vol. 6 (6), pp. 442-6.